Glutamate metabolism in HIV-1 infected macrophages: Role of HIV-1 Vpr

References

• Kilareski EM, Shah S, Nonnemacher MR, Wigdahl B. Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage. Retrovirology 2009; 6:118; PMID:20030845; http://dx.doi.org/10.1186/1742-4690-6-118
   PubMed Web of Science ®Google Scholar
• Brew BJ, Crowe SM, Landay A, Cysique LA, Guillemin G. Neurodegeneration and ageing in the HAART era. J Neuroimmune Pharmacol 2009; 4:163-74; PMID:19067177; http://dx.doi.org/10.1007/s11481-008-9143-1
   PubMed Web of Science ®Google Scholar
• Kogan M, Rappaport J. HIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic intervention. Retrovirology 2011; 8:25; PMID:21489275; http://dx.doi.org/10.1186/1742-4690-8-25
   PubMed Web of Science ®Google Scholar
• Connor RI, Chen BK, Choe S, Landau NR. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 1995; 206:935-44; PMID:7531918; http://dx.doi.org/10.1006/viro.1995.1016
   PubMed Web of Science ®Google Scholar
• Bukrinsky M, Sviridov D. Human immunodeficiency virus infection and macrophage cholesterol metabolism. J Leukoc Biol 2006; 80:1044-51; PMID:17056763; http://dx.doi.org/10.1189/jlb.0206113
   PubMed Web of Science ®Google Scholar
• Hollenbaugh JA, Munger J, Kim B. Metabolite profiles of human immunodeficiency virus infected CD4+ T cells and macrophages using LC-MS/MS analysis. Virology 2011; 415:153-9; PMID:21565377; http://dx.doi.org/10.1016/j.virol.2011.04.007
   PubMed Web of Science ®Google Scholar
• Noto A, Dessi A, Puddu M, Mussap M, Fanos V. Metabolomics technology and their application to the study of the viral infection. J Matern Fetal Neonatal Med 2014; 27 Suppl 2:53-7; PMID:25284178; http://dx.doi.org/10.3109/14767058.2014.955963
   PubMed Web of Science ®Google Scholar
• Sen S, Kaminski R, Deshmane S, Langford D, Khalili K, Amini S, Datta PK. Role of hexokinase-1 in the survival of HIV-1-infected macrophages. Cell Cycle 2015; 14:980-9; PMID:25602755; http://dx.doi.org/10.1080/15384101.2015.1006971
   PubMed Web of Science ®Google Scholar
• El Kasmi KC, Stenmark KR. Contribution of metabolic reprogramming to macrophage plasticity and function. Semin Immunol 2015; 7:S1044-5323
   Google Scholar
• Kaplon J, van Dam L, Peeper D. Two-way communication between the metabolic and cell cycle machineries: the molecular basis. Cell Cycle 2015; 14:2022-32; PMID:26038996; http://dx.doi.org/10.1080/15384101.2015.1044172
   PubMed Web of Science ®Google Scholar
• Andersen JL, Le Rouzic E, Planelles V. HIV-1 Vpr: mechanisms of G2 arrest and apoptosis. Exp Mol Pathol 2008; 85:2-10; PMID:18514189; http://dx.doi.org/10.1016/j.yexmp.2008.03.015
   PubMed Web of Science ®Google Scholar
• Guenzel CA, Hérate C, Benichou S. HIV-1 Vpr-a still “enigmatic multitasker.” Front Microbiol 2014; 5:127; PMID:24744753; http://dx.doi.org/10.3389/fmicb.2014.00127
   PubMed Web of Science ®Google Scholar
• Chen R, Le Rouzic E, Kearney JA, Mansky LM, Benichou S. Vpr-mediated incorporation of UNG2 into HIV-1 particles is required to modulate the virus mutation rate and for replication in macrophages. J Biol Chem 2004; 279:28419-25; PMID:15096517; http://dx.doi.org/10.1074/jbc.M403875200
   PubMed Web of Science ®Google Scholar
• Jacquot G, Le Rouzic E, David A, Mazzolini J, Bouchet J, Bouaziz S, Niedergang F, Pancino G, Benichou S. Localization of HIV-1 Vpr to the nuclear envelope: impact on Vpr functions and virus replication in macrophages. Retrovirology 2007; 4:84; PMID:18039376; http://dx.doi.org/10.1186/1742-4690-4-84
   PubMed Web of Science ®Google Scholar
• Sherman MP, De Noronha CM, Williams SA, Greene WC. Insights into the biology of HIV-1 viral protein R. DNA Cell Biol 2002; 21:679-88; PMID:12396611; http://dx.doi.org/10.1089/104454902760330228
   PubMed Web of Science ®Google Scholar
• Barrero CA, Datta PK, Sen S, Deshmane S, Amini S, Khalili K, Merali S. HIV-1 Vpr modulates macrophage metabolic pathways: a SILAC-based quantitative analysis. PLoS One 2013; 8(7):e68376; PMID:23874603; http://dx.doi.org/10.1371/journal.pone.0068376
   PubMedGoogle Scholar
• Erdmann N, Tian C, Huang Y, Zhao J, Herek S, Curthoys N, Zheng J. In vitro glutaminase regulation and mechanisms of glutamate generation in HIV-1-infected macrophage. J Neurochem 2009; 109:551-61; PMID:19222703; http://dx.doi.org/10.1111/j.1471-4159.2009.05989.x
   PubMed Web of Science ®Google Scholar
• Ferrarese C, Aliprandi A, Tremolizzo L, Stanzani L, De Micheli A, Dolara A, Frattola L. Increased glutamate in CSF and plasma of patients with HIV dementia. Neurology 2001; 57:671-5; PMID:11524477; http://dx.doi.org/10.1212/WNL.57.4.671
   PubMed Web of Science ®Google Scholar
• Jiang ZG, Piggee C, Heyes MP, Murphy C, Quearry B, Bauer M, Zheng J, Gendelman HE, Markey SP. Glutamate is a mediator of neurotoxicity in secretions of activated HIV-1-infected macrophages. J Neuroimmunol 2001; 117:97-107; PMID:11431009; http://dx.doi.org/10.1016/S0165-5728(01)00315-0
   PubMed Web of Science ®Google Scholar
• Tian C, Sun L, Jia B, Ma K, Curthoys N, Ding J, Zheng J. Mitochondrial glutaminase release contributes to glutamate-mediated neurotoxicity during human immunodeficiency virus-1 infection. J Neuroimmune Pharmacol 2012; 7:619-28; PMID:22527635; http://dx.doi.org/10.1007/s11481-012-9364-1
   PubMed Web of Science ®Google Scholar
• Ollenschlager G, Jansen S, Schindler J, Rasokat H, Schrappe-Bacher M, Roth E. Plasma amino acid pattern of patients with HIV infection. Clin Chem 1988; 34:1787-9; PMID:2901300
   PubMed Web of Science ®Google Scholar
• Levy DN, Refaeli Y, MacGregor RR, Weiner DB. Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A 1999; 91:10873-7; http://dx.doi.org/10.1073/pnas.91.23.10873
   Web of Science ®Google Scholar
• Jones GJ, Barsby NL, Cohen EA, Holden J, Harris K, Dickie P, Jhamandas J, Power C. HIV-1 Vpr causes neuronal apoptosis and in vivo neurodegeneration. J Neurosci 2007; 27:3703-11; PMID:17409234; http://dx.doi.org/10.1523/JNEUROSCI.5522-06.2007
   PubMed Web of Science ®Google Scholar
• Pendyala G, Want EJ, Webb W, Siuzdak G, Fox HS. Biomarkers for neuroAIDS: the widening scope of metabolomics. J Neuroimmune Pharmacol 2007; 2:72-80; PMID:18040828; http://dx.doi.org/10.1007/s11481-006-9041-3
   PubMed Web of Science ®Google Scholar
• Guo B, Chen B, Liu A, Zhu W, Yao S. Liquid chromatography-mass spectrometric multiple reaction monitoring-based strategies for expanding targeted profiling towards quantitative metabolomics. Curr Drug Metab 2012; 13:1226-43; PMID:22519369; http://dx.doi.org/10.2174/138920012803341401
   PubMed Web of Science ®Google Scholar
• Hass R, Brach M, Kharbanda S, Giese G, Traub P, Kufe D. Inhibition of phorbol ester-induced monocytic differentiation by dexamethasone is associated with down-regulation of c-fos and c-jun (AP-1). J Cell Physiol 1991; 149:125-31; PMID:1939341; http://dx.doi.org/10.1002/jcp.1041490116
   PubMed Web of Science ®Google Scholar
• You L, Zhang B, Tang YJ. Application of stable isotope-assisted metabolomics for cell metabolism studies. Metabolites 2014; 42:142-65; http://dx.doi.org/10.3390/metabo4020142
   Google Scholar
• Koivunen P, Hirsila M, Remes AM, Hassinen IE, Kivirikko KI, Myllyharju J. Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF. J Biol Chem 2007; 282:4524-32; PMID:17182618; http://dx.doi.org/10.1074/jbc.M610415200
   PubMed Web of Science ®Google Scholar
• Xiao M, Yang H, Xu W, Ma S, Lin H, Zhu H, Liu L, Liu Y, Yang C, Xu Y, et al. Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev 2012; 26:1326-38; PMID:22677546; http://dx.doi.org/10.1101/gad.191056.112
   PubMed Web of Science ®Google Scholar
• Deshmane SL, Mukerjee R, Fan S, Del Valle L, Michiels C, Sweet T, Rom I, Khalili K, Rappaport J, Amini S, Sawaya BE. Activation of the oxidative stress pathway by HIV-1 Vpr leads to induction of hypoxia-inducible factor 1alpha expression. J Biol Chem 2009; 284:11364-73; PMID:19204000; http://dx.doi.org/10.1074/jbc.M809266200
   PubMed Web of Science ®Google Scholar
• DeBerardinis RJ, Cheng T. Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene 2010; 29:313-24; PMID:19881548; http://dx.doi.org/10.1038/onc.2009.358
   PubMed Web of Science ®Google Scholar
• Wise DR, Thompson CB. Glutamine addiction: a new therapeutic target in cancer. Trends Biochem Sci 2010; 35:427-33; PMID:20570523; http://dx.doi.org/10.1016/j.tibs.2010.05.003
   PubMed Web of Science ®Google Scholar
• Niemiec T, Sikorska J, Harrison A, Szmidt M, Sawosz E, Wirth-Dzieciolowska E, Wilczak J, Pierzynowski S. Alpha-ketoglutarate stabilizes redox homeostasis and improves arterial elasticity in aged mice. J Physiol Pharmacol 2011; 62:37-43; PMID:21451208
   PubMed Web of Science ®Google Scholar
• Perry G, Nunomura A, Hirai K, Takeda A, Aliev G, Smith MA. Oxidative damage in Alzheimer disease: the metabolic dimension. J Neuropathol Exp Neurol 2001; 60:759-67; PMID:11487050; http://dx.doi.org/10.1093/jnen/60.10.994
   PubMed Web of Science ®Google Scholar
• Doi A, Iijima K, Kano S, Ishizaka Y. Viral protein R of human immunodeficiency virus type-1 induces retrotransposition and upregulates glutamate synthesis by the signal transducer and activator of transcription 1 signaling pathway. Microbiol Immunol 2015; 59:398-409; PMID:25990091; http://dx.doi.org/10.1111/1348-0421.12266
   PubMed Web of Science ®Google Scholar
• Erdmann N, Zhao J, Lopez AL, Herek S, Curthoys N, Hexum TD, Tsukamoto T, Ferraris D, Zheng J. Glutamate production by HIV-1 infected human macrophage is blocked by the inhibition of glutaminase. J Neurochem 2007; 102:539-49; PMID:17596215; http://dx.doi.org/10.1111/j.1471-4159.2007.04594.x
   PubMed Web of Science ®Google Scholar
• Zolotukhin S, Byrne BJ, Mason E, Zolotukhin I, Potter M, Chesnut K, Summerford C, Samulski RJ, Muzyczka N. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther 1999; 6:973-85; PMID:10455399; http://dx.doi.org/10.1038/sj.gt.3300938
   PubMed Web of Science ®Google Scholar
• Dietmair S, Timmins NE, Gray PP, Nielsen LK, Kromer JO. Towards quantitative metabolomics of mammalian cells: development of a metabolite extraction protocol. Anal Biochem 2010; 404:155-64; PMID:20435011; http://dx.doi.org/10.1016/j.ab.2010.04.031
   PubMed Web of Science ®Google Scholar